Year |
Citation |
Score |
2011 |
Chung E, Prelli F, Dealler S, Lee WS, Chang YT, Wisniewski T. Styryl-based and tricyclic compounds as potential anti-prion agents. Plos One. 6: e24844. PMID 21931860 DOI: 10.1371/Journal.Pone.0024844 |
0.493 |
|
2011 |
Yang J, Wadghiri YZ, Hoang DM, Tsui W, Sun Y, Chung E, Li Y, Wang A, de Leon M, Wisniewski T. Detection of amyloid plaques targeted by USPIO-Aβ1-42 in Alzheimer's disease transgenic mice using magnetic resonance microimaging. Neuroimage. 55: 1600-9. PMID 21255656 DOI: 10.1016/J.Neuroimage.2011.01.023 |
0.489 |
|
2010 |
Chung E, Ji Y, Sun Y, Kascsak RJ, Kascsak RB, Mehta PD, Strittmatter SM, Wisniewski T. Anti-PrPC monoclonal antibody infusion as a novel treatment for cognitive deficits in an Alzheimer's disease model mouse. Bmc Neuroscience. 11: 130. PMID 20946660 DOI: 10.1186/1471-2202-11-130 |
0.526 |
|
2010 |
Chung E, Prelli F, Yeoun D, Chang Y, Wisniewski T. Treatment of prion infection in vitro and in vivo Alzheimers & Dementia. 6. DOI: 10.1016/J.Jalz.2010.05.424 |
0.426 |
|
2010 |
Wisniewski T, Chung E, Ji Y, Sun Y, Kascsak R, Kascsak R, Strittmatter SM. Anti-PrPC monoclonal antibody infusion as a novel treatment for Aß oligomer cognitive deficits Alzheimers & Dementia. 6. DOI: 10.1016/J.Jalz.2010.05.2004 |
0.53 |
|
2009 |
Goni F, Estevez V, Yim L, Sun Y, Chung E, Carp R, Meeker C, Rubenstein R, Chabalgoity A, Wisniewski T. Mucosal vaccination of elk-PrP transgenic mice to prevent prion transmission via an oral route Alzheimers & Dementia. 5. DOI: 10.1016/J.Jalz.2009.07.138 |
0.471 |
|
2009 |
Wisniewski T, Prelli F, Scholtzova H, Chung E, Mehta PD, Kascsak R, Kascsak R, Goni F. Immunotherapy targeting abnormal protein conformation Alzheimers & Dementia. 5: 113. DOI: 10.1016/J.Jalz.2009.05.354 |
0.392 |
|
2008 |
Goñi F, Prelli F, Schreiber F, Scholtzova H, Chung E, Kascsak R, Brown DR, Sigurdsson EM, Chabalgoity JA, Wisniewski T. High titers of mucosal and systemic anti-PrP antibodies abrogate oral prion infection in mucosal-vaccinated mice. Neuroscience. 153: 679-86. PMID 18407424 DOI: 10.1016/J.Neuroscience.2008.02.051 |
0.514 |
|
2008 |
Scholtzova H, Kascsak RJ, Kerr DJ, Marchi EJ, Boutajangout A, Chung E, Quartermain D, Spinner DS, Wisniewski T. P2-405: Induction of toll-like receptor 9 signaling as a method for preventing or ameliorating Alzheimer's disease Alzheimer's & Dementia. 4: T492-T492. DOI: 10.1016/J.Jalz.2008.05.1484 |
0.402 |
|
Show low-probability matches. |